Prescription Drugs
Prescription Drug Importation: Can it Help America's Seniors?
Event
June 2005
Washington, DC
Remarks and Presentations now available.
As the debate over drug importation from Canada, the EU, and Japan continues in the 109th Congress and across the US, AARP’s Global Aging Program organized a symposium, "Prescription Drug Importation: Can It Help America’s Seniors?" that will help opinion leaders consider some of the fundamental questions surrounding the legislation. Specifically, this symposium focused on the impact of imported drugs on costs in the US and the safety of our pharmaceutical system.
Program/Speakers
|
Welcoming Remarks Ladan Manteghi, Director, AARP Office of International Affairs |
|
Introductory Remarks: " Prescription Drug Affordability: Importation and Safety" Bill Novelli, CEO, AARP |
Update of Importation Legislation
|
|
Impact of Importation on Rx Costs Introductions: John Rother Director of Policy and Strategy AARP Panelists:
|
|
Safety of Imported Medications Introductions: Lee Hammond Member AARP Board of Directors Panelists:
|
